Trilostane Suspension

Trilostane acts as a precise competitive inhibitor of the 3-beta-hydroxysteroid dehydrogenase enzyme, effectively suppressing the overproduction of cortisol to stabilize endocrine function in patients with hyperadrenocorticism. By integrating this active agent into a specialized liquid vehicle, the formulation ensures consistent drug dispersion and optimal bioavailability, harmonizing the drug’s potent inhibitory effects with reliable systemic absorption. This suspension delivery system provides critical clinical advantages by enabling exact, weight-based dose titrations that enhance therapeutic monitoring and improve administration compliance for patients requiring tailored endocrine management.